Hepatic disease and pregnancy: An overview of diagnosis and management

Critical Care Medicine

Volumn 33, Issue 10 SUPPL., 2005, Pages

  Guntupalli, Saketh R ^b   Steingrub, Jay ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Jaundice; Liver disease; Pregnancy

Indexed keywords

BIBLIOGRAPHIC DATABASE; CHOLESTASIS; EARLY DIAGNOSIS; FATTY LIVER; HELLP SYNDROME; HEPATITIS B; HEPATITIS C; HIGH RISK PREGNANCY; HUMAN; LABORATORY TEST; LIVER DISEASE; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; WILSON DISEASE;

EID: 26644431587     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000182555.39644.7F     Document Type: Review

References (56)

1. Ch'ng CL, Morgan M, Hainsworth I, et al: Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51:876-880;
2. Erratum: Gut 2003; 52:315
3. Sibai BM, Ramadan MK, Usta I, et al: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993; 169:1000
4. Ibdah JA, Bennet MJ, Rinaldo P, et al: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340:1723
5. Sibai BM, Taslimi MM, el-Nazer A, et al: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155:501-509
6. Goodlin RC: Preeclampsia as the great imposter. Am J Obstet Gynecol 1991; 164:1577-1581
7. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22
8. Knox TA, Olans LB: Liver disease in pregnancy. N Engl J Med 1996; 335:569-576
9. Martin JN Jr, Blake PG, Lowry SL, et al: The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164(6 Pt 1):1500-1509; Discussion 1509-1513
10. Castro MA, Fassett MJ, Reynolds TB, et al: Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy based on 28 consecutive cases. Am J Obstet Gynecol 1999; 181:389-395
11. Pockros P, Peters R, Reynolds T: Idiopathic fatty liver of pregnancy: Findings in ten cases. Medicine (Baltimore) 1984; 63:1
12. Sims HF, Brackett JC, Powell CK, et al: The molecular basis of pediatric long chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci 1995; 92:841-845
13. Treem WR, Shoup ME, Hale DE, et al: Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Gastroenterol 1996; 91:2293
14. Innes AM, Seargeant LE, Balachandra K, et al: Hepatic carnitine palimotoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res 2000; 47:43-45
15. Grunfeld JP, Pertuiset N: Acute renal failure in pregnancy. Am J Kidney Dis 1987; 9:359-362
16. Usta IM, Barton JR, Amon EA, et al: Acute fatty liver of pregnancy: An experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 1994; 171:1342
17. Castro MA, Goodwin TM, Shaw KJ, et al: Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 1996; 174:211-216
18. Castro MA, Fassett MJ, Telfer RB, et al: Reversible peripartum liver failure: A new perspective on the diagnosis, treatment and cause of acute fatty liver of pregnancy based on 28 consecutive cases. Am J Obstet Gynecol 1999; 181:289-295
19. Greenstein D, Henderson JM, Boyer TD: Liver hemorrhage: Recurrent episodes during pregnancy complicated by preeclampsia. Gastroenterology 1994; 106:1668-1671
20. Manas KJ, Welsh JD, Ranking RA, et al: Hepatic hemorrhage without rupture in preeclampsia. N Engl J Med 312:426
21. Arias F, Mancilla-Jimenez R: Hepatic fibrinogen deposits in preeclampsia: Immunofluorescent evidence. N Engl J Med 1976; 295:578-582
22. Merchant SH, Mathew P, Vanderjagt TJ, et al: Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Am J Obstet Gynecol 2005; 103:1055-1058
23. Barton JR, Sibai BM: Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1996; 174:1820
24. Barton JR, Sibai BM: HELLP and the liver diseases of preeclampsia. Clin Liver Dis 1999; 3:31-48
25. Stevenson JT, Graham DJ: Hepatic hemorrhage and the HELLP syndrome: A surgeon's perspective. Am J Surg 1995; 61:756-760
26. Hedner U, Erhardsten E: Potential role of recombinant factor VIIa in transfusion medicine. Transfusion 2002; 42:114-124
27. Williamson C, Hems LM, Goulis DG, et al: Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. Br J Obstet Gynecol 2004; 111:676
28. Germain A, Carvajal J, Glasinovic JC, et al: Intrahepatic cholestasis of pregnancy: An intriguing pregnancy related disorder. J Soc Gynecol Invest 2002; 9:10-14
29. Kroumpouzos G: Intrahepatic cholestasis of pregnancy: What's new? J Eur Acad Dermatol Venereol 2002; 16:316-318
30. Reyes H: The enigma of intrahepatic cholestasis of pregnancy: Lessons from Chile. Hepatology 1982; 2:87-96
31. Holzbach RT, Sivak DA, Braun WE: Familial recurrent intrahepatic cholestasis of pregnancy: A genetic study providing evidence for transmission of a sex limited, dominant trait. Gastroenterology 1983; 85:175-179
32. Kenyon AP, Piercy CN, Girling J, et al: Obstetric cholestasis, outcome with active management: A series of 70 cases. Br J Obstet Gynaecol 2002; 109:282
33. Heikkinen J, Maentausta O, Ylosta P, et al: Changes in serum bile acid concentrations during normal pregnancy and with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981; 88:240-245
34. Glantz A, Hanns-Ulrich M, Mattsson LA: Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40:467-473
35. World Health Organization.
36. Euler G, Wooten K, Baughman A, et al: Hepatitis B surface antigen prevalence among pregnant women in urban areas: Implications for testing, reporting and preventing perinatal transmission. Pediatrics 2003; 111
37. Xu DZ, Tan YP, Choi BC, et al: Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case control study. J Med Virol 2002; 67:20-26
38. Gao SZ: Research on the Prevention and Treatment of Viral Hepatitis. Beijing, 1993: 38-46, 286-291
39. Liaw YF, Tsai SL, Sheen IS, et al: Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 1998; 93:354
40. Wright TL, Mamish D, Combs C, et al: Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339:952
41. Van Zonneveld M, Niesters HGM, de Man A, et al: Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis virus infection J Viral Hepatitis 2003; 10:294-297
42. Guan-Guan S, Kong-Han P, Nian-Feng Z, et al: Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10:910-912
43. Alter MJ: Epidemiology of hepatitis C in the west. Semin Liver Dis 1995; 15:5-14
44. Silverman NS, Jenkin BK, Wu C, et al: Hepatitis C virus in pregnancy: Seroprevalence and risk factors for infection. Am J Obstet Gynecol 1993; 169:583-587
45. Bartolotti F, Resti M, Giacchino R, et al: Changing epidemiologic patterns of chronic hepatitis C virus in Italian children. J Pediatr 1998; 133:378-391
46. a. Gibb DM, Goodall RL, Dunn DT, et al: Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 2000; 9:356(9233):904-907
47. Yeung LT, King SM, Roberts EA: Mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 34:223
48. Murad SD, Valla DC, De Groen PC, et al: Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004; 39:500
49. Valla D, Le MG, Poynard T, et al: Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: A case-control study. Gastroenterology 1986; 90:807
50. Bogin V, Marcos A, Shaw-Stiffel T: Budd-Chiari syndrome: In evolution. Eur J Gastroenterol Hepatol 2005; 17:33-35
51. Attwell A, Ludkowski M, Nash R, et al: Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther 2004; 20:867-873
52. Grant W, McCashland T, Botha J, et al: Acute Budd Chiari syndrome during pregnancy: Surgical treatment and orthotropic liver transplantation with successful completion of the pregnancy liver transplantation. Liver Transpl 2003; 9:976-979
53. Bull PC, Thomas CR, Rommens JM, et al: The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes' gene. Nat Genet 1993; 5:327
54. Sternlieb I: Wilson's disease and pregnancy. Hepatology 2000; February:531-532
55. Kaushansky A, Frydman M, Kauffman H, et al: Endocrine studies of the ovulatory disturbances in Wilson's disease. Fertil Steril 1987; 47:270-273
56. Brewer GJ, Johnson VD, Dick RD, et al: Treatment of Wilson's disease with zinc: XVII: Treatment during pregnancy. Hepatology 2000; 31:364-370